Pregled bibliografske jedinice broj: 1195484
Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?
Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm? // Arthritis & Rheumatism, 64 (2012), 8; 2417-2425 doi:10.1002/art.34522 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1195484 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Clinical implications for cannabinoid use in the
rheumatic diseases: Potential for help or harm?
Autori
Fitzcharles, Mary-Ann ; McDougall, Jason ; Ste- Marie, Peter A. ; Padjen, Ivan
Izvornik
Arthritis & Rheumatism (0004-3591) 64
(2012), 8;
2417-2425
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
cannabinoids ; rheumatic diseases
Sažetak
Although use of cannabinoids and a clear understanding of the endocannabinoid system may be pertinent to the mechanisms and management of the rheumatic diseases, there remains limited evidence to support the therapeutic use of cannabinoids to date, and unanswered questions remain with regard to their true clinical efficacy and long-term risks. The ubiquitous distribution of cannabinoid receptors throughout the body, coupled with the known effects of cannabinoids on inflammation, pain, and even joint damage, should prompt further study in the rheumatic diseases. Indeed, preclinical studies look promising, with future protocols perhaps involving peripherally restricted cannabinoids or agents that boost endocannabinoid tone.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Ivan Padjen
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE